Healthcare

Medical AI market forecast highlights precision medicine and drug discovery

A new market outlook forecasts rapid expansion in medical AI, citing precision medicine, AI drug discovery, diagnostics, and patient management as key drivers and covering Saudi Arabia, the UAE, and Kuwait.

A medical AI market report projects that the sector will grow from an estimated $56.2 billion in 2026 to $1.05 trillion by 2036. The report identifies precision medicine and AI-enabled drug discovery as major growth drivers, alongside applications in diagnostics, patient management, clinical research, healthcare delivery, and life sciences. Saudi Arabia, the UAE, and Kuwait are included in the report’s country-level coverage of the Middle East and Africa market. The forecast indicates that AI adoption is expanding beyond isolated clinical pilots into broader healthcare and pharmaceutical workflows. For GCC healthcare organizations, the report highlights potential investment areas including predictive tools, personalized treatment, research automation, and intelligent patient-management systems, although the item is a market forecast rather than a specific deployment.

Original source: GlobeNewswire

Related RAQI solutions

In-depth analysis on RAQI Insight

Work with RAQI